Introduction
Ubiquitously expressed Shc proteins play a role in coupling growth factor receptor activation to intracellular signaling pathways and are major targets of tyrosine-phosphorylation following activation of receptor tyrosine kinases ; reviewed in Bon®ni et al., 1996) , and receptors that lack intrinsic tyrosine kinase activity including G-protein coupled receptors Chen et al., 1996) ; ligation of integrins (Wary et al., 1996) ; and in cells expressing activated Src Dilworth et al., 1994) , Sea (Crowe et al., 1994) or Lck (Baldari et al., 1995) . In addition, Shc is constitutively phosphorylated in human tumor cells with known tyrosine kinase gene alterations . Following tyrosinephosphorylation, Shc associates with the SH2 and SH3 domain-containing adaptor protein, Grb2 (Lowenstein et al., 1992; Rozakis-Adcock et al., 1992) . This interaction is mediated by the phosphorylated tyrosine residues 239 and 317 of Shc which are both found within a sequence conforming to a high anity binding site for the Grb2 SH2 domain (Salcini et al., 1994; van der Geer et al., 1996; Gotoh et al., 1996; Harmer and DeFranco, 1997) . The Grb2 SH3 domains mediate its stable association with the Ras guanine nucleotide exchange factor, Sos, and membrane localization of the Grb2-Sos complex results in activation of Ras Buday and Downward, 1993; Chardin et al., 1993; Egan et al., 1993; Rozakis-Adcock et al., 1993; Aronheim et al., 1994) . Thus, it has been proposed that Shc is involved in coupling the activation of cell surface receptors to Ras activation (Rozakis-Adcock et al., 1992) . Phosphorylation of Y239/Y240 may also lead to c-myc induction and suppression of apoptosis in BaF3 cells in a Ras-independent manner, suggesting that Shc has other functions (Gotoh et al., 1996) . In addition, Shc phosphopeptides containing residues Y239/Y240 bind to a variety of as yet unidenti®ed phosphoproteins (van der Geer et al., 1996) . Together, these data suggest that Shc may participate in diverse signal transduction pathways by interacting with multiple cytoplasmic signaling molecules through binding of SH2 domain-containing proteins to phosphorylated residues Y239, Y240 and Y317.
To elucidate novel signaling pathways downstream of Shc, we sought to identify molecules that associated speci®cally with the phosphorylated Y239/Y240 or Y317 residues of Shc. In this report, we describe the characterization of a novel protein, Gads (Grb2-related adaptor downstream of Shc) which possesses amino and carboxy terminal SH3 domains¯anking a central SH2 domain and a unique region rich in glutamine and proline residues. Gads shares the greatest identity with Grb2 and Grap suggesting its role as an adaptor molecule (Lowenstein et al., 1992; Clark et al., 1992; Suen et al., 1993; Feng et al., 1996; Trub et al., 1997) . The SH2 domain-binding speci®city of Gads appears to be similar to that of Grb2 and mediates the interaction of Gads with tyrosinephosphorylated Shc, Bcr-Abl and c-kit. In the context of the full-length molecule, the speci®city of the Gads SH3 domains is distinct from Grb2, suggesting that Gads may function to couple tyrosine-phosphorylated proteins to downstream eectors distinct from Sos and Ras.
Results

Cloning and expression of Gads (Grb2-related adaptor downstream of Shc)
To identify proteins interacting with tyrosine-phosphorylated Shc, a mixture of biotinylated phosphopeptides corresponding to the known Shc tyrosinephosphorylation sites (Y239, Y240 and Y317) were used to screen a 16-day mouse embryo expression library. Partial cDNAs encoding several known and novel SH2 domain-containing proteins were isolated (unpublished results). One of these partial cDNAs was found to contain an open-reading frame encoding an SH2 domain, a unique region rich in glutamine and proline residues, and a carboxy terminal SH3 domain; this partial cDNA was most closely related to the adaptor protein Grb2 (Lowenstein et al., 1992) . We have termed this protein Gads, for Grb2-related adaptor downstream of Shc. Comparison of the Gads nucleotide and protein sequence against the Genbank database (Benson et al., 1998) identi®ed a murine EST sequence (accession number AA175718) encoding an SH3 domain and a partial SH2 domain, which overlapped with the 5' coding region of Gads. To obtain the entire predicted open-reading frame of Gads, primers corresponding to the 5' sequence of the murine EST and to the 3' sequence of the partial cDNA isolated in the screen were used to PCR amplify cDNA made from an 11-day mouse embryo. The DNA sequence of the ampli®ed cDNA contains a putative open-reading frame containing 322 amino acids coding for a protein with a predicted molecular weight of 36.8 kDa. It contains an amino terminal SH3 domain, followed by an SH2 domain, a unique region (aa 150 ± 269) and a carboxy terminal SH3 domain (Figure 1a ). To con®rm the sequence of the 5' region of Gads, 5' RACE was performed (data not shown). The assembled 1.37 kb cDNA likely represents the fulllength cDNA since a stop codon is observed upstream from the putative initiating methionine in both the murine EST sequence and the 5'RACE product, and the size corresponds to the observed message size by Northern blotting (Figure 2) . We predict that a human gene in the region 22q12 encodes a Gads homologue (accession number Z82206) because it is 90.6% similar to the mouse protein. The protein sequences of the SH2 and SH3 domains of Gads are most similar to the adaptor protein Grb2 and the recently identi®ed Grb2-related adaptor protein, Grap (Figure 1b) (Feng et al., 1996; Trub et al., 1997) . Based on its similarity to these adaptor proteins, and its apparent lack of a catalytic region as deduced from the sequence, Gads likely encodes an adaptor protein.
To examine the expression pattern of Gads, Northern blot analyses were performed with poly(A)+RNAs isolated from embryonic and adult murine tissue, and adult human tissues. A probe corresponding to the unique region of Gads detected two major transcripts of 4 kb and 1.7 kb primarily in adult mouse spleen and testis and in day 11 ± 17 mouse embryos (Figure 2a ). Identical-sized transcripts were detected in human thymus and peripheral blood leukocytes (Figure 2b ). Examination of human cancer cell lines revealed high levels of Gads expression in K562 and MOLT-4 cells (Figure 2b) . A minor message was detected at 7.5 kb in most tissues examined. The Gads cDNA cloned from mouse embryo likely represents the observed 1.7 kb messages, as the assembled Gads cDNA is 1.37 kb not including the poly-A tract. The nature of the 4 kb and 7.5 kb messages is unknown, but both the unique region probe and a probe corresponding to the fulllength Gads detected all three messages (data not shown).
Gads binding to Shc is mediated by phosphorylation of tyrosine 239 or 317
To determine the speci®city of Gads interaction with the biotinylated Shc phosphopeptides, the puri®ed phage encoding the partial Gads cDNA were plated, protein expression induced, immobilized onto nitrocellulose ®lters and incubated with individual biotinylated Shc phosphopeptides or control peptides. The pY 239 Y 240 , pY 239 pY 240 , and pY 317 peptides bound to the immobilized Gads, whereas neither Y 239 pY 240 peptides nor the unphosphorylated peptides bound (Figure 3a) . This indicates that the Gads SH2 domain can speci®cally bind to phosphorylated Y239 or Y317 residues, which are within Grb2 SH2 consensus binding sites (pYXNX; where X is any amino acid), and does not bind to phosphorylated Y240, which is not within a Grb2-consensus binding site. Therefore, Gads and Grb2 SH2 domains likely have similar binding speci®cities. In addition, a tryptophan residue corresponding to W121 in the EF1 region of the Grb2 SH2 domain, which has been shown to be critical for binding speci®city (Marengere et al., 1994) , is conserved within the Gads SH2 domain (Figure 1a ). We also tested the binding of Gads to mutant Shc proteins in which each of the tyrosine-phosphorylation sites was replaced by phenylalanine (Y to F). The FLAG-tagged mutant Shc proteins become tyrosinephosphorylated when co-transfected with v-src in 293T cells, with the exception of the 3F mutant in which all three tyrosines (Y239, Y240, Y317) have been changed to a phenylalanine (Figure 3b ). GST-Gads bound to the FLAG-tagged Shc mutants when either the Y239 or Y317 residues were phosphorylated, but did not bind to the 3F mutant con®rming that Gads interaction with Shc is mediated by tyrosine-phosphorylation at these sites (Figure 3b ). In addition, the binding of wild type, F239/Y240 and F317 Shc mutants to Gads appeared to be less ecient than F239/F240 or the F240 mutant, suggesting that phosphorylation at tyrosine 240 may have an inhibitory eect on binding.
To verify that full-length Gads can associate with endogenous tyrosine-phosphorylated Shc, COS-1 cells were transiently transfected with pcDNA3.1 vector encoding HA-epitope tagged Gads (pcDNA3.1-HAGads). Following EGF-stimulation of transfected COS-1 cells, all three Shc isoforms were detected in the anti-HA immunoprecipitate (Figure 3c ), indicating that Shc is co-immunoprecipitated with HA-tagged Gads in a growth factor dependent manner. A 40 kDa protein corresponding to HA-tagged Gads was detected in the anti-HA immunoprecipitates, and also in the anti-Shc immunoprecipitate from EGF-stimulated cells, con®rming that HA-tagged Gads coimmunoprecipitates with Shc. Tyrosine-phosphorylated proteins of 40 kDa, 100 kDa and 175 kDa in addition to the p46, p52, and p66 Shc isoforms are coimmunoprecipitated with HA-Gads following EGFstimulation ( Figure 3c ). Subsequent immunoblotting of the membrane with anti-EGF receptor antibodies identi®ed the 175 kDa phosphoprotein as the EGF receptor (data not shown).
Gads possesses a unique SH3 domain-binding speci®city
To further identify binding partners for Gads and to compare its binding speci®city to that of Grb2 we used the K562 cell line which expressed high levels of Gads. Immobilized GST and GST-fusion proteins corresponding to the Gads SH2, SH3 domains, full-length Gads, or Grb2 were incubated with cell lysate and bound proteins were analysed by immunoblotting with anti-phosphotyrosine antibodies ( Figure 4 ). Similar sized phosphoproteins precipitated with both Gads and Grb2, although a major phosphoprotein of 120 kDa (identi®ed as Cbl) was absent in the fulllength Gads complexes. Stripping and immunoblotting of the membrane with anti-Shc antibodies identi®ed the 52 kD phosphoprotein as Shc, and indicated that Shc is able to associate with full-length Gads or the isolated Gads SH2 domain in vitro (Figure 4 ). Another phosphoprotein known to bind to Grb2 in K562 cells is the 210 kDa Bcr-Abl oncoprotein. Subsequent immunoblotting with anti-Abl antibodies revealed that Bcr-Abl was also bound to full-length Gads, and the isolated Gads SH2 and carboxy terminal SH3 domains ( Figure 4 ).
Many of the proteins which bind to the SH3 domains of Grb2 and Grap have been identi®ed and include Sos, Sam68 and Cbl (Rozakis-Adcock et al., 1993; Feng et al., 1996; Trub et al., 1997; Richard et al., 1995; Lock et al., 1996; Donovan et al., 1994) . Given the similarity of Gads with Grb2 and Grap we have examined the interaction of Gads or the isolated SH3 domains of Gads with these SH3 domain-binding proteins. Full-length Gads and the isolated amino terminal SH3 domain of Gads failed to bind to Sos, Sam68 or Cbl, whereas the isolated carboxy terminal SH3 domain bound to all of these proteins ( Figure 4 ). As expected, Grb2 bound to Sos, Sam68 and Cbl. In addition, no association between full-length Gads and Sos was detected in 293T cells transfected with v-src, p815 mastocytoma cells, PDGF stimulated Rat2 ®broblasts or anti-CD3 activated Jurkat T cells (data not shown). These results suggest that the binding of the Gads carboxy terminal SH3 domain is altered in the context of the full-length Gads protein and that Gads may couple to SH3 domain-binding proteins that are dierent than those that have been found to bind either Grb2 or Grap.
Gads binds to Bcr-Abl and c-kit through its SH2 domain
Both the isolated carboxy terminal SH3 domain and SH2 domain of Gads were observed to bind to Bcr-Abl in K562 cell lysate, suggesting that both domains are able to associate with Bcr-Abl. This is similar to the reported interaction between Grb2 and Bcr-Abl in Figure 3 Gads associates speci®cally with Shc pY239 or pY317. (a) Puri®ed phage encoding the partial Gads cDNA were plated, protein expression induced, immobilized onto nitrocellulose ®lters and incubated with biotinylated Shc phosphopeptides or control peptides preconjugated to streptavidin-alkaline phosphatase as indicated. Bound peptides were detected by colourimetric reaction with NBT-BCIP. (b) 293T cells were transfected with v-src expression vector alone (7), or in combination with expression vector encoding FLAG-tagged full-length wildtype Shc (wt) or FLAG-tagged full-length Shc containing point mutations of each of the tyrosinephosphorylation sites (F 239 F 240 , F 239 Y 240 , Y 239 F 240 , F 317 , 3F). Relative transfection eciency was con®rmed by Western blotting of whole cell lysate (wcl) from the transfected 293T cells with anti-FLAG antibody (upper panel). The tyrosine-phosphorylation status of individual FLAG-tagged Shc mutants was determined by performing anti-FLAG immunoprecipitations of the transfected 293T cell lysate, following by Western blot analysis with anti-phosphotyrosine antibody (middle panel). In vitro binding experiments using puri®ed GST-Gads were performed, and bound FLAG-tagged Shc mutant proteins detected by immunoblotting with anti-FLAG antibody (bottom panel). (c) COS-1 cells were transfected with pcDNA3.1-HA-Gads, unstimulated (7) or stimulated (+) with EGF, and immunoprecipitations performed using a non-speci®c antibody (anti-mouse IgG: RaM), anti-Shc antibody, or anti-HA antibody. Immunoprecipitates and whole cell lysates (wcl) were subjected to Western blotting with anti-phosphotyrosine antibody conjugated to HRP to detect tyrosine-phosphorylated proteins (top panel). The blot was striped, cut lengthwise and separately reprobed with antiShc antibody (middle panel) or anti-HA antibody (bottom panel) a c b which both the isolated SH2 and SH3 domains of Grb2 bound to Bcr-Abl in vitro (Pendergast et al., 1993; Puil et al., 1994) . To determine which domain mediates the interaction with Bcr-Abl in the context of the full-length Gads protein, the SH3 domains or SH2 domain of full-length Gads were inactivated and assayed for their ability to precipitate tyrosinephosphorylated proteins from K562 cell lysate ( Figure  5A ). Gads amino terminal and carboxy terminal SH3 domains were inactivated through P47L and P313L point mutations, respectively, while the SH2 domain was inactivated through an R83K point mutation; mutation of the corresponding amino acids in Grb2 was previously demonstrated to block SH3 and SH2 domain-mediated interactions (Fukazawa et al., 1995) . The Gads mutant de®cient in SH2 domain-binding (SH2*) did not precipitate the 210 kDa phosphoprotein corresponding to Bcr-Abl, as identi®ed by stripping the blot and Western blotting with anti-Abl antibodies ( Figure 5 and data not shown), while the Gads mutants de®cient in SH3 domain-binding (N*/ C*, N*/C, or N/C*) still precipitated Bcr-Abl, implying that the interaction between Gads and Bcr-Abl is primarily mediated through the Gads SH2 domain. In addition, mutation of the Gads SH2 domain abrogated association with Shc, as identi®ed by stripping the blot and Western blotting with anti-Shc antibodies ( Figure  5 and data not shown), con®rming that the SH2 domain of Gads speci®cally mediates its interaction with Shc. Interestingly, binding of an unidenti®ed a b Figure 5 Gads interacts with Bcr-Abl and c-kit via its SH2 domain. (a) Puri®ed, immobilized GST or GST-fusion proteins corresponding to full-length wildtype Gads (wt) or full-length Gads with an inactivating point mutation in the amino terminal SH3 domain (N*/C SH3), in the carboxy terminal SH3 domain (N/C* SH3), in both SH3 domains (N*/C* SH3) or in the SH2 domain (SH2*) were incubated with K562 cell lysate, and bound proteins analysed by immunoblotting with anti-phosphotyrosine antibody. As a positive control for phosphotyrosine-containing proteins, total cell lysate was also analysed. Bcr-Abl and Shc were identi®ed by stripping the blot and immunoblotting with anti-Abl and anti-Shc antibodies, respectively (data not shown). (b) Puri®ed, immobilized GST or GST-fusion proteins corresponding to full-length wildtype Gads (wt) or full-length Gads with an inactivating point mutation in the SH2 domain (SH2*) were incubated with P815 cell lysate, and bound proteins analysed by immunoblotting with anti-phosphotyrosine antibody. c-kit and Shc were identi®ed by stripping the blot and immunoblotting with anti-c-kit and anti-Shc antibodies, respectively (data not shown) Figure 4 Gads possesses a unique SH3 domain-binding speci®city. Puri®ed, immobilized GST or GST-fusion proteins corresponding to the Gads SH2, amino terminal or carboxy terminal SH3 domains (N-SH3, C-SH3), full-length Gads (Gads), or Grb2 were incubated with K562 cell lysate and the bound proteins analysed by SDS ± PAGE, and immunoblotting with anti-phosphotyrosine antibodies. The blot was subsequently stripped and reprobed with anti-Shc, anti-Abl, anti-Sam68, anti Sos1, and anti-Cb1 antibodies as described in Materials and methods phosphoprotein of 100 kDa (p100) was lost in Gads mutants in which the carboxy terminal SH3 domain was inactivated (N/C* SH3) suggesting that p100 may be a speci®c target of the Gads carboxy terminal SH3 domain in vivo. Mutation of the amino terminal SH3 domain did not appear to alter the pro®le of phosphotyrosine-containing proteins bound by Gads.
The proto-oncogene c-kit encodes a receptor tyrosine kinase required for the normal development of melanocytes, germ cells and hematopoetic cells in the mouse (van der Geer, et al., 1994) . Both Grb2 and Grap SH2 domains have been shown to interact with c-kit (Tauchi et al., 1994b; Feng et al., 1996) . To investigate whether Gads also interacts with activated c-kit we have used the mastocytoma cell line P815 which expresses a mutant c-kit protein with a constitutively active kinase domain. The full-length Gads protein precipitated a tyrosine phosphorylated protein corresponding to c-kit from p815 cell lysates. The Gads SH2 domain mutant (SH2*) did not precipitate c-kit con®rming that the interaction is mediated by the SH2 domain ( Figure 5B ). In addition, longer exposures of the blot revealed the presence of a 52 kDa phosphoprotein precipitated by Gads but not by the SH2 mutant which was identi®ed as Shc by stripping and immunoblotting with anti-Shc antibodies (data not shown).
Gads protein expression
To analyse endogenous Gads protein expression, polyclonal antisera were generated against two dierent peptides within the unique region of Gads. The reactivity of pre-immune and immune Gads antisera was tested on Gads protein that was in vitro transcribed and translated from pBS-Gads (Figure 6a ). An immunoreactive band of 40 kDa was detected in the anti-Gads immunoprecipitate from the in vitro transcribed and translated Gads cDNA, and absent in pre-immune immunoprecipitates. This indicates that the anity-puri®ed anti-Gads antibodies speci®cally react with Gads protein in both immunoprecipitations and in Western blotting. Endogenous Gads protein was also detected in murine and human T cell lines (CTLL2 and Jurkat, respectively) and in K562 cells (Figure 6a) . Notably, the human Gads protein displays a slightly slower mobility relative to mouse Gads likely due to variation in the proline content of the unique region of the human and mouse proteins (unpublished data). Anti-Gads immunoprecipitations were also performed in a variety of other cell lines including COS-1, 293T, NIH-3T3 and BaF3 cells, and Gads expression subsequently assayed by Western blotting with antiGads antibody (Figure 6b ). Gads was not detected in any of these cell lines, suggesting that Gads expression is mainly restricted to hematopoietic cells. This is in agreement with the Northern expression analyses which detects Gads expression predominantly in the thymus and peripheral blood lymphocytes.
Gads is associated with Shc and Bcr-Abl in K562 cells
To examine the binding of endogenous Gads to phosphotyrosine-containing proteins, K562 cell lysates were immunoprecipitated with anti-Gads antibodies, and associated proteins analysed by Western blotting with anti-phosphotyrosine antibody ( Figure  7a) ; for comparison, cell lysate, anti-Shc, and anti-Abl immunoprecipitates were also included. Whereas a wide range of phosphoproteins were observed to coimmunoprecipitate with both Shc and Bcr-Abl, only two predominant 210 and 190 kDa phosphoproteins co-immunoprecipitated with Gads. The co-immunoprecipitating 210 kDa phosphoprotein was identi®ed as Bcr-Abl by subsequent immunoblotting with antiAbl antibodies (data not shown). Bcr-Abl was seen to co-immunoprecipitate with Gads, and as previously demonstrated, with Grb2 ( Figure 7b) (Pendergast et al., 1993; Puil et al., 1994) . We next examined whether endogenous Gads co-immunoprecipitates with Shc. Anti-Gads and anti-Shc immunoprecipitations were performed using K562 cell lysate and Western blotted for the presence of Gads (Figure 7b ). Gads was detected in the anti-Shc immunoprecipitate suggesting that Gads and Shc are associated in vivo. In addition, the anti-Gads immunoprecipitates were also subsequently immunoblotted with anti-Sos antibodies. In keeping with the results of the in vitro binding experiments, Sos did not co-precipitate with endogenous Gads (data not shown). Together, these experia b Figure 6 Western blot analysis of Gads protein expression. (a) In vitro transcription and translation reaction of pBS or pBS-Gads utilizing rabbit reticulocyte lysate were performed as outlined in Materials and methods. The reaction mixtures, or lysates from CTLL2, Jurkat or K562 cells were subjected to immunoprecipitation with pre-immune sera or anity-puri®ed anti-Gads antibody, followed by Western blotting with anti-Gads antibody. (b) Lysates from various cell lines: COS-1, 293T, NIH-3T3, BaF3, CTLL2, and Jurkat cells, were subjected to immunoprecipitation with anity-puri®ed anti-Gads antibody followed by Western blotting with anti-Gads antibody ments indicate that Gads is associated with Shc and Bcr-Abl in vivo, and identi®es Gads as a potentially novel component of the Bcr-Abl signaling complex.
Discussion
In this report, we describe the identi®cation and characterization of Gads, a novel SH3-SH2-SH3 domain-containing adaptor protein. Gads is structurally similar to the Grb2 and Grap adaptor proteins, suggesting that Gads is a new member of the`Grb2-family' of adaptor proteins (Lowenstein et al., 1992; Clark et al., 1992; Suen et al., 1993; Feng et al., 1996; Trub et al., 1997) . Interestingly, Gads possesses a unique region rich in proline and glutamine residues located between its SH2 domain and carboxy terminal SH3 domain which distinguishes it from both Grb2 and Grap.
Gads is predominantly expressed in hematopoietic cells. The recently cloned Grap adaptor is also speci®cally expressed in lymphoid tissue and in various hematopoietic cell lines, and has been proposed to function downstream of the T cell receptor (Feng et al., 1996; Trub et al., 1997) . Given its restricted expression we postulate that Gads is also involved in signaling processes within T lymphocytes and are currently investigating this possibility. Indeed we have found that Gads is highly expressed in primary mouse lymphocytes and binds to a restricted set of tyrosinephosphorylated proteins following T cell receptor activation (SK Liu and CJ McGlade, manuscript in prep) .
Gads speci®cally binds to Shc derived peptides which contain phosphorylated tyrosine residues 239 or 317, and likewise is able to interact in vitro with Shc mutants that retain either of these phosphorylation sites. Both Y239 and Y317 are embedded in amino acid sequences which conform to the Grb2 SH2 domain-binding consensus sequence (pYXNX), thus the Gads SH2 domain likely possesses a binding speci®city similar to that of the Grb2 and Grap SH2 domains Trub et al., 1997) . However we have found that in vivo, the pro®le of phosphotyrosine-containing proteins bound to Gads in K562 cells and in activated lymphocytes (unpublished results) is not identical to that detected in anti-Grb2 immunoprecipitates suggesting that the binding of Gads to its phosphorylated targets is restricted. Similarly, Trub and colleagues have noted that the Grap SH2 domain appears to precipitate two predominant phosphotyrosine-containing proteins, p36/38, from activated Jurket T cells while numerous tyrosine-phosphorylated proteins are observed to precipitate with Grb2 (Trub et al., 1997) . Thus the binding of both Gads and Grap appears to be more restricted than that of Grb2. However, we cannot rule out that the dierences in the pro®les of phosphotyrosine-containing proteins observed to precipitate with Gads are a function of restricted SH3 domainmediated interactions.
We have found that in isolation the carboxy terminal Gads SH3 domain can interact with Sos, Cbl, and Sam68 while the amino terminal SH3 domain does not appear to possess any detectable anity for these proteins. Furthermore, full-length Gads does not interact with any of these proteins including Sos, in vivo or in vitro, suggesting that Gads likely functions to couple Bcr-Abl, Shc, and perhaps additional tyrosinephosphorylated proteins to a downstream pathway that is independent of Sos activation of Ras. The dierence in the binding speci®cities between the full-length Gads protein and the isolated SH3 domain may be due to the presence of the 120 amino acid unique region in the full-length molecule which could alter the spatial orientation of the SH3 domains of Gads and contribute to their interaction with speci®c targets. Alternatively, this region could regulate the interaction of the carboxy terminal SH3 domain with its targets via an intramolecular contact between proline rich sequences in the unique region and the carboxy terminal SH3 domain. This mode of regulation could be analogous to the recently described low-anity intramolecular interaction between the SH3 domain of Src and Hck kinases with the`SH2-kinase linker' that contributes to the inactive kinase conformation (Xu et al., 1997; Sicheri et al., 1997) . A similar regulatory mechanism has been proposed to modulate the activity of the adaptor protein Crk-II (Ana® et al., 1996) . Finally, the unique region could mediate the interaca b Figure 7 Gads associates in vivo with Shc and Bcr-Abl. (a) K562 cell lysates were immunoprecipitated with anti-Gads, anti-Shc, and anti-Abl antibodies, and immunoblotted with anti-phosphotyrosine antibodies. (b) Anti-Gads, anti-Shc, and RaM (negative control) immunoprecipitations were performed using K562 cell lysates, and the presence of Gads was assessed by Western blotting with anti-Gads antibody. The presence of Bcr-Abl was analysed by anti-Gads, anti-Grb2 and anti-mouse IgG immunoprecipitation from K562 cell lysates, followed by Western blotting with anti-Abl antibody tion of Gads with another protein which could sterically hinder the binding of SH3 domain target proteins. Experiments are underway to assess the eects of the unique region of Gads in protein complex formation and function.
The oncogenic 210 kDa Bcr-Abl protein is associated with chronic myelogenous leukemia (reviewed in Gotoh and Broxmeyer, 1997) . Bcr-Abl mediated transformation is thought to rely on activation of the Ras pathway (Sawyers et al., 1995) , and evidence suggests that this involves adaptor proteins such as Shc, Grb2 and SHP-2 which act to couple Bcr-Abl to Sos (Tauchi et al., 1994a; Pendergast et al., 1993; Puil et al., 1994; Gishizky et al., 1995) . Like Grb2, Gads is also associated with Bcr-Abl through its SH2 domain, however, Gads does not recruit Sos to this complex. In addition, we have found that although Grb2 and Gads are expressed at roughly equivalent levels in K562 cells, much more Bcr-Abl can be immunprecipitated with Grb2 than Gads. This dierence suggests that the interaction of Gads with tyrosine-phosphorylated proteins is regulated in vivo or that the Gads may be bound to targets in addition to Shc and Bcr-Abl that compete for binding or preclude the association of Gads with Bcr-Abl and Shc in these cells. We propose that Gads may couple activated receptors and tyrosinephosphorylated proteins such as Shc and Bcr-Abl to novel downstream signaling pathways. The identification of in vivo targets of the Gads SH3 domains, such as p100, will reveal its functions in tyrosine kinase mediated signaling pathways. , that were pre-conjugated to streptavidin-alkaline phosphatase (BioRad) as described in Sparks et al. (1996) . Filters were washed ®ve times with TBST and detection performed through a colorimetric NBT-BCIP reaction. Positive plaques were isolated and two subsequent rounds of screening were performed to purify the phage. The pExLox plasmids were isolated from the phage according to the manufacturer's directions and the inserts sequenced.
Materials and methods
Screening of expression libraries with phosphopeptides
Plasmids
The Gads full-length cDNA (aa 1 ± 322) was ampli®ed through Polymerase Chain Reaction (PCR) from an 11-day Mouse Embryo Marathon-Ready cDNA library (Clontech, Palo Alto, CA, USA) using cDNA speci®c primers and cloned in-frame into the pGEX-2TK vector (Pharmacia, Uppsala, Sweden) or pBluescript (pBS) vector (Stratagene, La Jolla, CA, USA). The amino terminal SH3 (aa 1 ± 65), SH2 (aa 48 ± 152), and carboxy terminal SH3 (aa 257 ± 322) regions were ampli®ed from Gads full-length cDNA and cloned into the pGEX-2TK vector. To generate HA-tagged Gads cDNA, the full-length Gads coding region was subcloned into pcDNA3.1-HA (a generous gift of Bryan Snow, AMGEN Institute, Ontario, Canada). Full-length Grb2 cDNA in pGEX-2T and v-src pECE were kind gifts from Mike Moran (University of Toronto, Canada)
The full-length mouse Shc cDNA was cloned into the pFLAG-CMV2 vector (Kodak) to generate the wt ShcpFLAG-CMV2 expression vector. Tyrosine to phenylalanine mutations in Shc tyrosine-phosphorylation sites (F 239 F 240 , F 239 Y 240 , Y 239 F 240 , F 317 , F 239 F 240 F 317 (3F)) were generated by PCR using mutagenic primers and cloned into the pFLAG-CMV2 vector. PCR-based mutagenesis was employed to generate inactivating P47L and P313L mutations in the amino and carboxy terminal SH3 domains of Gads, and an inactivating R83K mutation in the SH2 domain of Gads; the mutants were cloned into the pGEX-2TK vector.
Cell culture 293T, COS-1, P815 and NIH-3T3 cells were cultured in Dulbecco's Modi®ed Eagle medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (Gibco BRL, Gathersburg, MD, USA), 200 mM L-glutamine, 5 U/ml penicillin C, and 5 mg/ml streptomycin sulfate. K562 and Jurkat cells were cultured in RPMI 1640 medium supplemented as above. BaF3 cells were maintained in RPMI 1640 supplemented as above with the addition of recombinant IL-3 (100 pg/ml) (R&D Systems, Minneapolis, MN, USA), while CTLL2 cells were maintained in RPMI 1640 supplemented as above with the addition of recombinant IL-2 (2 U/ml) (Boehringer-Mannheim, Mannheim, Germany).
Preparation of GST-fusion proteins
Recombinant GST-fusion protein were expressed and puri®ed as previously described . Puri®ed protein bound to glutathione-sepharose 4B beads (Pharmacia) were resuspended in an equal volume of NP-40 lysis bufer (50 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM EDTA, 100 mM ZnCl 2 , 1% (v/v) Nonidet-P40, 10% (v/v) glycerol) containing complete protease inhibitors (Boehringer-Mannheim) and 1 mM DTT and stored at 7808C. Each of the puri®ed GST-fusion proteins was quantitated by SDS ± PAGE followed by Coomassie staining, and comparison with BSA standards.
Transient transfections
293T or COS-1 cells were grown to approximately 50% con¯uence in 10 cm culture dishes and co-transfected with 5 mg of each expression vector using Lipofectin (Gibco-BRL) according to manufacturer's instructions. Transfected cells were harvesed 48 h post-transfection.
EGF-stimulation of transfected COS-1 cells was carried out as follows: 16 h following transfection COS-1 cells were starved in 0.5% (v/v) fetal bovine serum in DMEM for 24 h and then stimulated with human recombinant EGF (80 nM) Upstate Biotechnology, Lake Placid, NY, U.S.A.) in DMEM at 378 for 5 min.
In vitro transcription and translation For in vitro transcription and translation reactions, 1 mg of pBS or pBS-Gads was incubated with rabbit reticulocyte lysate and reaction components for 90 min at 308C according to manufacturer's directions (Promega, Madi-son, WI, USA). Each 50 ml reaction was then immunoprecipitated with either pre-immune sera or anity-puri®ed anti-Gads antibody, and Western blotted with anitypuri®ed anti-Gads antibody as outlined below.
Antibodies
Polyclonal Gads antisera were generated by immunizing rabbits with peptides coupled to keyhole limpet hemocyanin, corresponding to two dierent sequences within the unique region of Gads: H1-A, GEEIRPSVNRKLSDH or H1-B, LMHRRHTDPVQLQA. Crude antisera were affinity-puri®ed over an immobilized peptide (H1-A or H1-B) column (Pierce). For anti-Gads immunoprecipitations, 2 mg of anity-puri®ed anti-Gads antibody (H1-B) was used; 1 : 250 dilution of anity-puri®ed anti-Gads antibody (H1-A) was used for immunoblotting. Anity-puri®ed anti-Shc antibodies were prepared and used as previously described . Anity-puri®ed anti-HA antibody (12CA5) was purchased from Boehringer-Mannheim and 2 mg was used for immunoprecipitation. For Western blotting of HA-tagged proteins, anti-HA antibody (12CA5) conjugated to HRP (Boehringer-Mannheim) was used at a 1 : 1000 dilution. Anti-FLAG M2 antibody (Kodak, Rochester, NY, USA) was used at 2 mg/sample for immunoprecipitation and a dilution of 1 : 500 used for Western blotting. The anti-phosphotyrosine antibody 4G10 (Upstate Biotech) was used for Western blotting at a 1 : 1500 dilution. Anti-cbl, anti-Sam68, anti-c-kit and antiSos1 antibodies were purchased from Santa Cruz, Santa Cruz, CA USA and used for Western blotting at a dilution of 1 : 250. Anti-Abl antibody was used at a 1 : 100 dilution for Western blotting (Calbiochem, Bedford, MA, USA). Anity-puri®ed anti-GST antibody was used for Western blotting at a dilution of 1 : 5000 and was a kind gift of Susan McCracken (AMGEN Institute).
Immunoprecipitation and Western blotting
Each 10 cm plate of transfected COS-1 or 293T cells or 2610 7 CTLL2, Jurkat and K562 cells were lysed in 1 ml of PLC lysis buer (50 mM HEPES pH 7.5, 150 mM NaC1, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 1.5 mM MgC1 2 , 1 mM EDTA, 10 mM NaPPi, 100 mM NaF, 1 mM Na 3 VO 4 ) containing complete protease inhibitors and the lysate clari®ed by centrifugation at 13 500 r.p.m. at 48C for 10 min. Clari®ed lysate was incubated with antibodies as described above and 50 ml of 20% (v/v) protein G-or protein A-sepharose (Sigma) at 48C with gentle rotation for 90 min. Immune complexes were washed three times in 1 ml NP-40 lysis buer, bound proteins eluted by boiling for 5 min in reducing SDS-Laemmli sample buer and resolved by SDS ± PAGE. Proteins were electrophoretically transferred to Immobilon-P membrane (Millipore, Bedford, MA, USA), and incubated in a blocking solution of 5% non-fat skim milk powder (w/v) in TBST or in 1% BSA (w/v) in TBST (for anti-phosphotyrosine Western blotting) for a minimum of 1 h prior to addition of antibody overnight at 48C. Membranes were washed three times in TBST and incubated at RT for 30 min with an appropriate secondary antibody conjugated to HRP. Following incubation with secondary antibodies, membranes were washed three times in TBST and developed using ECL (Amersham, Buckinghamshire, UK) as per the manufacturer's instructions.
In vitro binding experiments
The lysate of transfected cells or 2610 7 K562 cells were prepared as described above, and incubated with approximately 5 mg of GST-fusion protein coupled to glutathionesepharose 4B beads for 90 min at 48C. The beads were washed three times with NP-40 lysis buer, resuspended in reducing SDS-Laemmli sample buer, the proteins resolved on a polyacrylamide gel and transferred to Immobilon-P membrane. Western blotting and detection of immunorreactive bands was carried out as described above.
Northern blot analysis Northern blots containing poly (A) + mRNA isolated from a variety of murine and human tissues and human cancer cell lines were purchased from Clontech.
A 0.36 kb fragment (unique region) or a 0.99 kb fragment of the Gads cDNA was 32 P-radiolabeled by random hexamer priming (Pharmacia) and hybridizied with Northern blots at 10 6 c.p.m./ml overnight at 428C in a solution of 50% formamide, 46SSPE. 1% sodium dodecyl sulfate (SDS), 0.5% skim milk powder, 10% dextran sulfate and 10 mg/ml sheared salmon sperm DNA. Blots were washed twice for 10 min per wash at room temperature in 26SSC, 0.1% SDS, then twice for 10 min per wash at 558C in 0.16 SSC, 0.1% SDS, and exposed to X-OMAT ®lm (Kodak). The blots were also probed with radiolabeled b-actin cDNA (Clontech) as an indicator of RNA loading.
